VJHemOnc is committed to improving our service to you

SOHO Italy 2020 | Impact of COVID-19 on CLL treatment in Italy

VJHemOnc is committed to improving our service to you

Antonio Cuneo

Antonio Cuneo, MD, PhD, University of Ferrara, Ferrara, Italy, outlines the impact of the COVID-19 pandemic on the treatment of chronic lymphocytic leukemia (CLL) in Italy, and outlines the risk of COVID-19 high-risk disease in patients with CLL. Dr Cuneo also discusses the use of the BTK inhibitor ibrutunib, which may show efficacy against the COVID-19 pandemic. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter